Home
Conditions
Tumor Virus Infections

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies

Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Not Yet Recruiting

The Mother-Daughter Project: Merck-4

NCT07240220

Conditions: Cervical Dysplasia, Communicable Diseases, DNA Virus Infections, +19 more
Locations: Moi University Eldoret, Kenya

View Trial Details

Not Yet Recruiting

Multicenter Prospective Non-randomized Controlled Study of Ella Photodynamic Therapy for Cervical HSIL/CIN2

NCT07306260

Conditions: CIN 2, Communicable Diseases, DNA Virus Infections, +16 more
Locations: Women's Hospital School Of Medicine Zhejiang University Hangzhou, Zhejiang, China

First People's Hospital of Hangzhou Hangzhou, Zhejiang, China

Hangzhou Linping District first People's Hospital Hangzhou, Zhejiang, China

First Affiliated Hospital of Ningbo University Ningbo, Zhejiang, China

View Trial Details

Not Yet Recruiting

Autologous Bedside CD19 CAR T-cell Therapy for B-ALL

NCT07277504

Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: The General Hospital of Western Theater Command Chengdu, Sichuan, China

View Trial Details

Not Yet Recruiting

Zuberitamab for EBV Infection Post-Allo-HSCT

NCT07261215

Conditions: DNA Virus Infections, EBV Infection, Epstein-Barr Virus Infections, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Allogeneic UCB-derived CAR-T for B-ALL

NCT07256353

Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: The General Hospital of Western Theater Command Chengdu, Sichuan, China

View Trial Details

Not Yet Recruiting

A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms

NCT07234045

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations: China Institute of Hematology and Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma

NCT07168291

Conditions: Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma (DLBCL), +18 more
Locations: First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China

View Trial Details

Not Yet Recruiting

EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma

NCT07138989

Conditions: Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
Locations: Sun Yat-sen Universitty Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.

NCT07133776

Conditions: Chidamide, DNA Virus Infections, Epstein-Barr Virus (EBV) Infection, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

NCT03429413

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Tumor Virus Infections

Tumor Virus Infections trial results

Related conditions